These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7834920)

  • 1. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis.
    Kohler LJ; Gohara AF; Hamilton RW; Reeves RS
    Clin Nephrol; 1994 Oct; 42(4):263-5. PubMed ID: 7834920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis.
    Murray AN; Cassidy MJ; Templecamp C
    Nephron; 1987; 46(4):373-6. PubMed ID: 3658067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly progressive glomerulonephritis during antituberculous therapy.
    Hirsch DJ; Bia FJ; Kashgarian M; Bia MJ
    Am J Nephrol; 1983; 3(1):7-10. PubMed ID: 6837655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis.
    Ogata H; Kubo M; Tamaki K; Hirakata H; Okuda S; Fujishima M
    Nephron; 1998; 78(3):319-22. PubMed ID: 9546693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
    Kuroda F; Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Wada A
    Kekkaku; 1999 Nov; 74(11):803-7. PubMed ID: 10599213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure due to rifampicin.
    Agnihotri MS; Bansal S; Kumar A
    Indian J Chest Dis Allied Sci; 1990; 32(2):125-8. PubMed ID: 2083961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Acute renal failure caused by rifampicin].
    Manasia M; Paul G
    Nouv Presse Med; 1975 Apr; 4(16):1212. PubMed ID: 1161475
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary tuberculosis, cryoglobulinemia and immunecomplex glomerulonephritis.
    Teruel JL; Matesanz R; Mampaso F; Lamas S; Herrero JA; Ortuno J
    Clin Nephrol; 1987 Jan; 27(1):48-9. PubMed ID: 2949902
    [No Abstract]   [Full Text] [Related]  

  • 11. Crescentic glomerulonephritis associated with rifampicin in a patient co-infected with tuberculosis and human immunodeficiency virus.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Apr; 65(4):284-9. PubMed ID: 16629229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure--a complication of new multidrug regimen for treatment of leprosy.
    Dedhia NM; Almeida AF; Khanna UB; Mittal BV; Acharya VM
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):380-2. PubMed ID: 3746041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditis.
    Wiggins KJ; Galanos JW; Hill PA; Scott KV; Langham RG
    J Nephrol; 2007; 20(4):489-94. PubMed ID: 17879217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
    Reis FJ; Bedran MB; Moura JA; Assis I; Rodrigues ME
    Am Rev Respir Dis; 1990 Nov; 142(5):996-9. PubMed ID: 2240853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
    Lee SK
    Bull Int Union Tuberc; 1976; 51(1):109-13. PubMed ID: 1030269
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal failure due to continuous rifampicin.
    Power DA; Russell G; Smith FW; Simpson JG; MacLeod AM; Friend JA; Catto GR
    Clin Nephrol; 1983 Sep; 20(3):155-9. PubMed ID: 6627764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of side effects on intermittent rifampicin regimen.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.